Latest Observability News

Altech Batteries confirms the safety and durability of its CERENERGY® sodium-nickel-chloride battery technology through rigorous testing, while its Silumina Anodes™ pilot plant in Germany achieves a 50% capacity increase. An independent DNV study endorses the technology’s promising future.

Sequoia Financial Group has responded to an ASX price query, denying any undisclosed material information behind recent trading fluctuations and reaffirming compliance with listing rules amid ongoing ASIC investigations.

Bowen Coking Coal has appointed voluntary administrators after failing to secure fresh capital or negotiate with key creditors, reflecting mounting challenges in Queensland's coal sector. The administration aims to enable a sale or recapitalisation while maintaining operations at its Burton Mine Complex.

TMK Energy has commenced drilling its seventh pilot well at the Gurvantes XXXV Coal Seam Gas Project, reporting positive reservoir pressure tests and advancing partnerships to fast-track development.

Solis Minerals has kicked off diamond drilling at its Chancho al Palo copper-gold project in Peru, revealing promising visual mineralisation including visible gold, while advancing permits and funding to support further exploration.

Torque Metals has confirmed an 8-metre extension of high-grade pyrrhotite-associated gold mineralisation at its Paris Gold Project, with a continuous zone now reaching approximately 52 metres. Down-hole electromagnetics suggest further mineralisation potential beyond current drilling.

Immutep Limited advances its pivotal Phase III lung cancer trial and reports promising results across multiple oncology and autoimmune programs, supported by a solid cash position to fund operations through 2026.

Infini Resources has appointed experienced contractors to commence a pivotal Phase 2 drilling campaign at its Portland Creek Uranium Project, aiming to unlock high-grade uranium targets along a 6 km mineralised trend.

White Energy Company Limited reported promising exploration results across multiple Australian projects targeting critical minerals, alongside progress in commercialising its innovative coal briquetting technology in South Africa.

Biotron Limited has successfully raised $1.27 million through an entitlement issue to fund its antiviral drug development, including a promising Hepatitis B compound that cleared its initial animal safety study.

Battery Age Minerals Ltd has responded to an ASX price query, denying undisclosed information and attributing recent trading activity to a new research report and the launch of its maiden drilling program.

Chimeric Therapeutics has advanced its CHM CDH17 CAR-T program with dose escalation and FDA Fast Track status, alongside promising early results in AML trials and a successful $6.6 million capital raise.